Podcasts about Shah

The mental-health testimony everyone's been waiting for showed up this week in the Lindsay Clancy trial, courtesy of psychiatrist Dr. Sejal Shah, who treated Clancy during her hospital stay. Clancy, 34, of Duxbury, Massachusetts, is charged with three counts of murder and three counts of strangulation in the deaths of her children — Cora, 5, Dawson, 3, and Callan, 7 months — who prosecutors allege she strangled with exercise resistance bands inside the family's Summer Street home on January 24, 2023. She's pleaded not guilty. Her attorney, Kevin Reddington, is building an insanity defense around severe postpartum psychosis and psychiatric overmedication.Shah described Clancy experiencing delirium in the hospital and testified that Clancy changed her health care proxy to her parents during that period — a procedural detail that ends up saying a lot about her state of mind at the time. Shah also gave the court a broader picture of Clancy's mental health, testimony both sides will likely revisit heavily as this trial moves forward.After the alleged killings, Clancy is accused of attempting suicide by jumping from a second-story window, leaving her paralyzed from the waist down. Her husband, Patrick Clancy, was running errands when it happened and has since relocated to Manhattan, where he's spoken publicly about his wife's mental health. The trial is underway in Plymouth Superior Court and is expected to run several weeks.LinksJoin Our SubStack For AD-FREE ADVANCE EPISODES & EXTRAS!: https://hiddenkillers.substack.com/Want to comment and watch this podcast as a video? Check out our YouTube Channel. https://www.youtube.com/channel/UC8-vxmbhTxxG10sO1izODJg?sub_confirmation=1Instagram https://www.instagram.com/hiddenkillerspod/Facebook https://www.facebook.com/hiddenkillerspod/Tik-Tok https://www.tiktok.com/@hiddenkillerspodX Twitter https://x.com/TrueCrimePodDisclaimerThis publication contains commentary and opinion based on publicly available information. All individuals are presumed innocent until proven guilty in a court of law. Nothing published here should be taken as a statement of fact, health or legal advice.Hashtags#LindsayClancy #DuxburyTragedy #PostpartumPsychosis #TrueCrime #PlymouthCounty #CoraDawsonCallan #InsanityDefense #KevinReddington #TrueCrimeToday #Breaking

Dr. Sejal Shah, a psychiatrist involved in Lindsay Clancy's hospital treatment, testified this week, and her account moves the trial squarely into the medical territory the defense has been building toward. Clancy, 34, of Duxbury, Massachusetts, faces three counts of murder and three counts of strangulation over the deaths of her children — 5-year-old Cora, 3-year-old Dawson, and 7-month-old Callan — who prosecutors allege she strangled with exercise resistance bands inside the family's Summer Street home on January 24, 2023. She's pleaded not guilty, and her attorney, Kevin Reddington, is arguing an insanity defense rooted in severe postpartum psychosis and psychiatric overmedication.Shah testified about Clancy experiencing delirium during her hospital stay and told the court Clancy changed her health care proxy over to her parents — a decision that, however it gets read by either side, says something about where things stood. Shah went on to describe Clancy's broader mental health picture at the time, testimony that's likely to sit at the center of both the prosecution's and the defense's closing arguments once this trial gets there.The alleged strangulations were followed by an alleged suicide attempt — Clancy is said to have jumped from a second-story window and is now paralyzed from the waist down. Her husband, Patrick Clancy, was out running errands during the killings and has since relocated to Manhattan, where he's spoken to the press about his wife's mental health. The trial continues in Plymouth Superior Court and is expected to run several weeks.LinksJoin Our SubStack For AD-FREE ADVANCE EPISODES & EXTRAS!: https://hiddenkillers.substack.com/Want to comment and watch this podcast as a video? Check out our YouTube Channel. https://www.youtube.com/channel/UC8-vxmbhTxxG10sO1izODJg?sub_confirmation=1Instagram https://www.instagram.com/hiddenkillerspod/Facebook https://www.facebook.com/hiddenkillerspod/Tik-Tok https://www.tiktok.com/@hiddenkillerspodX Twitter https://x.com/TrueCrimePodDisclaimerThis publication contains commentary and opinion based on publicly available information. All individuals are presumed innocent until proven guilty in a court of law. Nothing published here should be taken as a statement of fact, health or legal advice.Hashtags#LindsayClancy #DuxburyTragedy #PostpartumPsychosis #TrueCrime #PlymouthCounty #CoraDawsonCallan #InsanityDefense #KevinReddington #HiddenKillers #Breaking

બાળગીત: મમ્મી મારી…લેખિક: લતા હિરાણીપ્રસ્તુતિ: અંજના શાહMusic by William_King from Pixabay

બાળકોને રમવા દો લેખક: નરેશ ડામોર વાંચન સ્વર: અંજના શાહMusic by William_King from Pixabay

Fitz Koehler sits down with celebrity doctor (you saw him in the Liquid Death SUPER BOWL ad) Dr. Darshan Shah, founder of Next Health, to explore his powerhouse journey from surgery to building a 25-location longevity empire blending functional medicine, biomarker-driven care, and cutting-edge biohacking. They tackle the wellness wheel, practical health-tracking tests like hemoglobin A1c, safe peptide use, sleep, strength, and high-tech recovery tools—including saunas, cryotherapy, and hyperbaric oxygen. This episode combines big-picture prevention and personalized medicine with tips you can actually use: monitoring metabolic health, protecting precious muscle while losing weight, and creating daily habits that supercharge your health span and performance. Thanks for keeping The Fitzness Show in the top 3% of all podcasts worldwide. Please subscribe, share, and leave a review.  Order signed copies of You. Supercharged! The Healthy Cancer Comeback Series books at Fitzness.com are on sale now! Join the Hottie Body Fitzness Challenge group on Facebook!  

Today my guests are my colleagues Shreyas Narla and Kadambari Shah. Shreyas is a research scholar and Kadambari is a research associate at the Mercatus Center with the India program. We talked about completing five years of the 1991 Project, how it started, it's scope, the oral histories of the reformers in 1991, papers, essays, fellowships and much more.  Recorded July 10th, 2026. Read a full transcript enhanced with helpful links. Prefer to watch this episode, see the full length video here. Connect with Ideas of India Follow us on X Follow Shruti on X Follow Shreyas on X Follow Kadambari on X Click here for the latest Ideas of India episodes sent straight to your inbox. Timestamps: 00:00:00 - Intro 00:01:44 - The Origin Story 00:11:07 - Launching the Oral Histories Initiative 00:20:47 -Documentation and Memory 00:37:47 - Building the Repository 00:46:18 - The 1991 Project Website 00:58:11 - Walking with Giants 01:06:45 - Where are all the Women? 01:11:27 - Making Economic Reforms 'Sexy' Again 01:22:43 - The Importance of Intergenerational Interaction 01:34:33 - Incubating New Talent 01:41:39 - Gratitude and Acknowledgments 01:53:19 - Outro

If mealtimes in your home feel like a power struggle, or you're exhausted from worrying whether your kid is eating well, this episode will come as a relief. Dr. Lisa Damour and Reena Ninan revisit their conversation with Dr. Reshma Shah, a Stanford-affiliated pediatrician, public health expert, and co-author of the award-winning book “Nourish: The Definitive Plant-Based Nutrition Guide for Families.” With over 20 years of experience in academic and clinical pediatrics and a deep commitment to family-centered approaches to food and wellbeing, Dr. Shah offers a low-pressure, evidence-based roadmap for helping kids develop a healthy relationship with food.

If mealtimes in your home feel like a power struggle, or you're exhausted from worrying whether your kid is eating well, this episode will come as a relief. Dr. Lisa Damour and Reena Ninan revisit their conversation with Dr. Reshma Shah, a Stanford-affiliated pediatrician, public health expert, and co-author of the award-winning book “Nourish: The Definitive Plant-Based Nutrition Guide for Families.” With over 20 years of experience in academic and clinical pediatrics and a deep commitment to family-centered approaches to food and wellbeing, Dr. Shah offers a low-pressure, evidence-based roadmap for helping kids develop a healthy relationship with food.

Transformation Tip: The healthiest leader is the one who leads themselves first.What if your greatest leadership breakthrough isn't found in another business book—but in taking ownership of your own health?Steve Chua welcomes Dr. Darshan Shah, board-certified surgeon, longevity physician, Founder &CEO of Next Health, and host of the EXTEND Podcast. After performing nearly 20,000 surgeries, Dr. Shah experienced his own health crisis that completely transformed his view of medicine. Today, he helps leaders optimize their health before disease ever develops.Together, Steve and Darshan explore the surprising connection between leadership and wellness, why burnout is often a sign to pivot toward purpose, and how practicing what you preach builds authentic influence.In this episode you'll learn:Why empathy is essential to effective leadershipHow Dr. Shah reversed his own chronic diseaseThe role of functional medicine alongside traditional healthcareWhy expensive biohacks can't replace healthy fundamentalsHow passion—not perseverance alone—helps overcome burnoutWhy great leaders become living examples of their messageConnect with Dr. Darshan ShahWebsite: drshah.comNext Health Clinics: next-health.comPodcast: Extend — one of the most-listened-to medical podcasts in the worldDr. Shah Socials: https://www.drshah.comhttps://www.instagram.com/darshanshahmd/https://www.instagram.com/extend_podcast/https://www.youtube.com/darshanshahmdhttps://www.facebook.com/DarshanShahMDhttps://www.linkedin.com/in/darshanshahmd/https://x.com/DarshanShah_MDTransformation Application:Your business has KPIs. Your health should too. Take ownership of the habits that fuel your body, sharpen your mind, and strengthen your leadership. The greatest transformation begins with self-leadership. Connect On Social:Podcast Facebook PageSteve Facebook Steve InstagramSteve LinkedInPete FacebookPete Instagram Pete LinkedIn

Game Over नहीं… Modi–Shah का Final Move अभी बाकी है! | FCRA, Delimitation & More | Abhishek Tiwari

At the 2026 National ICE-T Conference in Orlando, CancerNetwork® sat down with a variety of expert researchers and clinicians to discuss the latest developments in immune effector therapy across different hematologic oncology populations. Sessions at the meeting covered practical considerations for integrating CAR T-cell therapies, bispecific antibodies, and other modalities into the treatment of those with multiple myeloma, lymphoma, and other hematologic malignancies.First, Benjamin Diamond, MD, an assistant professor of Clinical Medicine, a member of the Sylvester Myeloma Institute, and a member of the Myeloma Genomic Lab at the University of Miami Miller School of Medicine, spoke about his presentation reviewing bispecific antibodies for the management of multiple myeloma. In his session, Diamond stated that bispecific T-cell engagers are altering the landscape of multiple myeloma care and will eventually become an option in the frontline setting. With many products to choose from, Diamond emphasized sequencing these novel therapies wisely and stressed aggressive infection prophylaxis as a mandatory facet of care.Next, Tiba Al Sagheer, PharmD, BCOP, BCACP, a pharmacy quality improvement coordinator for transplant and cellular therapy at Miami Cancer Institute of Baptist Health South Florida discussed her presentation focused on defining new thresholds for monitoring and mitigating toxicities associated with CAR T-cell therapy. She described considerations for balancing early toxicity intervention against the risk of blunting efficacy depending on the specific CAR T-cell product used during treatment. Ultimately, she noted that that there is still no definitive answer or threshold for initiating prophylaxis for toxicity associated with CAR T, and that differentiating between immune effector cell (IEC)–associated hemophagocytic lymphohistiocytosis (HLH)–like syndrome (IEC-HS) and cytokine release syndrome (CRS) represents an ongoing challenge in the field.Finally, Nikesh N. Shah, MD, and Carlos Silva Rondon, MD, shared their perspectives on a debate regarding the roles of bispecific antibodies and CAR T-cell therapies in relapsed/refractory follicular lymphoma. In his presentation, Shah, a hematologist-oncologist at Tampa General Hospital who specializes in hematologic malignancies, including aggressive lymphomas and acute lymphoblastic leukemia, took the position that bispecific antibodies should be used prior to CAR T-cell therapy for most patients, although both treatments have utility in the field. Silva Rondon, a hematologist, oncologist, and bone marrow transplant specialist at Moffitt Malignant Hematology and Cellular Therapy at Memorial Healthcare System/Memorial Cancer Institute in Pembroke Pines, advocated for CAR T-cell therapy during the debate but acknowledged that both modalities can make up a complementary strategy for overcoming relapsed/refractory follicular lymphoma.References Diamond B. Bispecific antibodies for the management of multiple myeloma. Presented at the 2026 National ICE-T Conference; July 18, 2026; Orlando, FL. Sagheer TA. Thresholds and therapeutics: a precision approach to CAR T toxicity management. Presented at the 2026 National ICE-T Conference; July 18, 2026; Orlando, FL. Shah N. Debate: bispecific antibodies vs CAR-T in follicular lymphoma. Presented at the 2026 National ICE-T Conference; July 18, 2026; Orlando, FL. Silva C. CAR-T cell therapy for relapsed follicular lymphoma. Presented at the 2026 National ICE-T Conference; July 18, 2026; Orlando, FL.

durée : 00:11:25 - Le Fil de l'histoire - En 1979, le shah d'Iran fuyait le pays pour finalement se réfugier aux Etats-Unis, ce pays qui l'avait soutenu presque jusqu'au bout. Simultanément, un autre homme fort, charismatique et habile, apparaissait et allait bientôt prendre la tête de la révolution iranienne : l'ayatollah Khomeiny... Vous aimez ce podcast ? Pour écouter tous les épisodes sans limite, rendez-vous sur Radio France

Within the span of a week, federal immigration agents shot and killed two people in Maine and Texas, and another was hit by a truck and killed in Florida after trying to avoid ICE agents. A fourth person recently died in ICE custody after reportedly being denied medication. Their deaths prompted yet another round of questioning as to how federal immigration agents have amassed so much power and so little accountability. This week on The Intercept Briefing, host Akela Lacy speaks with Naureen Shah, of the American Civil Liberties Union, and Nayna Gupta, of the American Immigration Council, on the consequences of allowing the government to build a national policing force that's bringing Trump's war on immigrants into communities across the country.“The $240 billion injection that the Trump administration has given ICE and Border Patrol make these agencies — which already were the largest federal law enforcement agencies — make them far larger than anything that we've seen at the federal law enforcement level,” says Shah. “Their budgets are bigger than that of many, actually most militaries around the world.”“It's not really just about who they're hiring and even the training that they're getting — it's the message that they get all the way from the top,” says Shah. “And of course, the message after the killings of Alex Pretti and Renee Good was, you have immunity in the conduct that you're engaged in. It's basically a message of, you're going to get away with it. Don't worry about it.”“The signal from the very top of the administration is unmistakable: Arrest as many people as possible without regard for the actual impact on public safety, without regard for the killings that may result, the harm that results.”Congressional funding for those agencies has outpaced any action on comprehensive immigration reform. And with Republicans pushing to strip voting rights from millions of Americans while campaigning against immigrants, says Gupta, the solution is to neutralize their argument by creating a path to citizenship — a proposal with broad bipartisan support. “There's no question that the immigration enforcement agenda that this administration is pursuing ties to voting rights. Now, the question is, given that, how do we still make sure we're offering solutions and reforms that can be viable and build a broad enough coalition of support to overwhelm that far-right base and the way they've weaponized this issue?” Gupta says. “I think those kinds of conversations are a more effective antidote to the far right's effort to weaponize the immigration system, not only to hurt immigrants, but to hurt core democratic rights like the right to vote.”Full transcript: https://interc.pt/4wk7elzKeep our investigations free and fearless at theintercept.com/join. Hosted on Acast. See acast.com/privacy for more information.

What if the smartest thing you can do with your single biggest advantage is hand it to the competition?Brendan and Bianca Shah run Chado Tea Room and the wholesale arm, International Tea Importers, the family business their father Devan built into one of the engines of America's specialty tea culture. When he died in 2016, the two of them inherited a company that lived entirely in his head and rebuilt it from first principles.In this conversation, we get into why selling their best tea to direct competitors grew the entire category and made the brand their real moat, how the wholesale and retail sides power a single flywheel, and why paring a 300-tea catalog down to its essentials is what unlocks growth.If you're competing on product alone, this shows you what it looks like to build something nobody can copy.That's Brendan and Bianca Shah. To learn more about Chado Tea Room, visit chadotea.com._________________________________________________________Free 5-Day Restaurant Marketing Masterclass – This is a live training where you'll learn the exact campaigns Josh has built and tested in real restaurants to attract new guests, increase visit frequency, and generate sales on demand. Save your spot at restaurantbusinessschool.com

In this episode of the Psynautical Podcast, I sit down with Axay Shah, founder of Raw Foodiest and author of In Nature We Trust: A Raw Food Manifesto for Energy, Healing & Longevity.We explore Axay's personal health journey, what inspired him to adopt a 100% raw plant-based lifestyle, and why he believes returning to whole, natural foods can have a profound impact on energy, healing, and long-term health. We also discuss common misconceptions about raw foods, nutrition, longevity, and practical steps anyone can take to improve their health.Whether you're interested in holistic health, nutrition, longevity, or simply looking for new perspectives on wellness, this episode offers an engaging conversation on living closer to nature.In This EpisodeAxay's journey into raw foodsThe philosophy behind In Nature We TrustRaw food nutrition and common misconceptionsEnergy, vitality, and longevityBuilding sustainable healthy habitsPractical tips for improving your dietThe future of holistic healthLearn More About Axay Shah

Mary welcomes back historian William Federer to bring us the sweeping history of Iran, from Genesis 10 to modern times. And it’s a wild ride. Who were those Persians? Dating back to Elam, grandson of Noah, they have occupied a huge part of world history, biblical and secular alike. We will look at those biblical skirmishes, the middle ages, and the rise of the British Empire when Islam was forced to grapple with the then-Christian element of Europe. As we look at the Ottoman Turks, who started out as friends of the Jew following their expulsion from Spain, we find that just when the Ottoman Empire started to disappear from the world scene, Zionism arose and -surprise! – oil entered the picture as nation states began to industrialize. Then it’s on to shahs and ayatollahs and the 1970s under Jimmy Carter who gave us Hamas, Hezbollah and Houthis, simply by campaigning for the Ayatollah over the Shah. Didn’t I warn you it’s a wild ride? And all of it valuable history as we try and make sense of our world. There is no one quite like Bill Federer and his wealth of knowledge about just about everything.     Stand Up For The Truth Videos: https://rumble.com/user/CTRNOnline & https://www.youtube.com/channel/UCgQQSvKiMcglId7oGc5c46A

FCRA, Delimitation, Vande Matram Bills ने विपक्ष को हिलाया | Modi - Shah | Rahul vs Kejriwal

In this episode of The Birth Lounge Podcast, HeHe sits down with pelvic floor physical therapist Hayley Kava, founder of UMA Pelvic Health, to tackle one of the most common pregnancy complaints that doesn't get nearly enough attention: SI joint pain. If you've been told pregnancy pain is "just part of it," this conversation is your reminder that you don't have to simply suffer through it. Hayley explains what's actually happening in your pelvis during pregnancy, why SI joint pain develops, and how your pelvic floor, core, ribcage, breathing, and overall movement patterns all work together. Together, HeHe and Hayley break down why treating the pelvis in isolation often misses the bigger picture, how pregnancy hormones and your changing biomechanics influence pain, and why small changes to the way you move, stand, breathe, and rest can make a huge difference. They also discuss practical tools like SI belts, belly support bands, Pilates balls, yoga blocks, and gentle movement strategies, along with when those tools can help... and when they might not. Hayley also shares why pelvic floor physical therapy isn't just about internal exams (and yes, those are always optional), how to build a supportive birth team, and why individualized care is one of the best investments you can make during pregnancy. Whether you're already dealing with pelvic pain or hoping to prevent it, this episode is packed with practical, evidence-based strategies to help you move more comfortably, feel more supported, and better understand your changing body throughout pregnancy. 00:00 Stop Blaming Pelvic Floor 01:03 Pelvic Floor Basics 01:56 Meet Hayley Kava 03:19 Why SI Pain Matters 06:43 SI Joint Anatomy 09:18 Normal Asymmetry Patterns 12:20 Pubic Pain and Rolling 15:52 Inhibit Then Retrain 17:56 Rubiks Cube Body Model 20:10 Stop Bracing to Sneeze 21:34 Pregnancy Posture Fixes 25:31 Preparing for Labor Moves 29:14 Build Your Care Team 33:39 Pregnancy Compensation Patterns 34:36 Spotting Habitual Postures 36:46 Mindful Pain Check Ins 38:29 Shifting Stance And Sitting 41:29 Tension Beyond Pelvic Floor 43:23 Guarding And SI Joint Myths 46:16 Ribs Hip And Big Picture 47:57 Internal Exam Is Optional 50:38 Daily Tools And Movement 56:43 Services Access And Wrap Up   Guest Bio: Hayley became a pelvic floor therapist in 2017 after a birth injury opened her eyes to the limitations in traditional pelvic rehab. Hayley took her Postural Restoration and Sports Medicine background and dug deep into the literature. Over the years developing an integrative whole person method to treat the pelvic floor. She has become passionate about sharing this method with not only her clients and staff but to the masses via social media, online classes and various trainings for clinicians looking to take a different approach to pelvic rehab. You can learn more about those offerings at hayleykavapt.com   SOCIAL MEDIA: Connect with HeHe on Instagram: https://www.instagram.com/tranquilitybyhehe/  Connect with Hayley on IG: https://www.instagram.com/hayleykavapt/ BIRTH EDUCATION: Learn how to stay in control of your birth and reduce the risk of unnecessary interventions in our Avoid a C-Section Webinar. HeHe breaks down the cascade of interventions, explains what's really happening in the hospital, and shares practical strategies to protect your birth plan, advocate for yourself, and navigate labor with confidence. Perfect for anyone who wants a positive, informed hospital birth experience: https://www.thebirthlounge.com/csection Feeling nervous about speaking up in labor? Our Scripts for Advocacy give you the exact words to handle the most common conversations that can make or break your birth experience. From declining unnecessary interventions to asking the right questions about procedures, these scripts empower you to stay in control, speak confidently, and protect your birth plan — even when the pressure is on. Think of it as your personal toolkit for advocating like a pro, so you can focus on your baby, not the stress: https://www.thebirthlounge.com/Scripts-for-Advocacy And if you haven't grabbed it yet… Snag my free Pitocin Guide to understand the risks, benefits, and red flags your provider may not be telling you about, so you can make informed, powerful decisions in labor: https://www.thebirthlounge.com/pitocin Join The Birth Lounge for judgment-free, evidence-based childbirth education from HeHe that shows you exactly how to navigate hospital policies, avoid unnecessary interventions, and have a trauma-free labor experience, all while feeling wildly supported every step of the way: https://www.thebirthlounge.com/ Want prep delivered straight to your phone? Download The Birth Lounge App for bite-sized birth and postpartum tools you can use anytime, anywhere: https://www.thebirthlounge.com/app   LINKS AND RESEARCH MENTIONED: www.umapelvichealth.com www.hayleykavapt.com Kiapour A, Joukar A, Elgafy H, Erbulut DU, Agarwal AK, Goel VK. Biomechanics of the Sacroiliac Joint: Anatomy, Function, Biomechanics, Sexual Dimorphism, and Causes of Pain. Int J Spine Surg. 2020 Feb 10;14(Suppl 1):3-13. doi: 10.14444/6077. PMID: 32123652; PMCID: PMC7041664. Joukar, Amin MS∗; Shah, Anoli MS∗; Kiapour, Ali PhD∗; Vosoughi, Ardalan Seyed MS∗; Duhon, Bradley MD†; Agarwal, Anand K. MD∗; Elgafy, Hossein MD∗; Ebraheim, Nabil MD∗; Goel, Vijay K. PhD∗. Sex Specific Sacroiliac Joint Biomechanics During Standing Upright: A Finite Element Study. SPINE 43(18):p E1053-E1060, September 15, 2018. | DOI: 10.1097/BRS.0000000000002623

Jason gives you a quick overview of Context for the Islamic Republic of Iran, Part 5.Read the essay here: https://historywiththeszilagyis.org/hwts288   Find us on Socials:The Network: @BQNPodcasts The Show: @HistorySzilagyi. Chrissie: @TheGoddessLivia.  Jason: @JasonDarkElf.Send topic suggestions via Twitter or on our Facebook page History with the Szilagyis.History with the Szilagyis is supported by our patrons: PatiSusan Capuzzi-De ClerckLaura DullKris HillBetty LarsenVince LockeJoin these wonderful supporters by visiting patreon.com/historywiththeszilagyis. The BQN Podcast Collective is brought to you by our listeners. Special thanks to these patrons on Patreon whose generous contributions help to produce this podcast and the many others on our network! BQN Podcasts are made possible by the generous contributions of listeners like you. We extend our heartfelt gratitude to our Patreon patrons, whose support has been instrumental in producing the network!Chad RidingMei MMischief CaitG. Haukur GuðmundssonJoe SaporitoMartin MarigomenJaxDaniel EvansLars Di ScenzaSamuel JohnsonJenediahRyan DamonWilliam J. JacksonJonathan SnowJerry AntimanoBe Tellarite, Not TellaWrongShalimar LuisStevenSusan L. DeClerckDavidJason AndersonMatt HarkerDavid WillettCarl WondersVera BTim CooperPeter HongTom Van ScotterJim McMahonJustin OserThad HaitChristina De Clerck-SzilagyiJoe MignoneYou can join this illustrious list by becoming a patron here: https://www.patreon.com/BQN

Tariffs have been front page news since the 2024 presidential campaign. In February 2025 (and again in April 2025), President Donald Trump issued executive orders levying tariffs that threatened small and large businesses alike. But only one CEO of a small family business stepped forward...with only one major law firm.In this episode, Rick Woldenberg, CEO of Learning Resources, Inc. and Hand2Mind, and his counsel, Pratik Shah, Head of the Supreme Court and Appellate Practice at Akin Gump tell the impossible story of how they overturned the Trump tariffs in less than a year.Woldenberg and Shah met on Good Friday in April 2025 and by Tuesday after Easter weekend, filed a complaint in District Court challenging the tariffs, having never met each other in person. This is a story about how aligning on goals, committing to clear and honest feedback, and being engaged and open to other opinions can be rocket fuel for a successful client relationship (and result).

We need Agressive Modi & Shah Against CJP & Anti-India Forces

Modi Shah Wilt in Front of Street Thugs Again | Nadda's Curious Meet | Give Delhi Police Free Hand

Shah's Halal started out as a food cart on the streets of Queens in New York City in 2005, selling gyros and rice bowls with Afghan flavors. The simple menu used 100% halal ingredients, a rarity at the time, but the demand for halal food kept growing. Although the quick-service menu now is more extensive, it's still very simple, said CEO Khalid Mashriqi during the podcast. Burgers, chicken sandwiches, wings, and falafel are options along with the rice bowls and gyros, and Shah's differentiates from other Middle Eastern concepts by its focus on halal ingredients and signature sauces — some now available at retail. The company is vertically integrated, complete with a USDA-certified facility for processing meat and a commissary, which makes halal sourcing and preparation less challenging. Franchising is powering growth, although a number of locations are company-owned. Listen to learn how Mashriqi and his team intend to focus on expanding to smaller, more diverse communities, how Shah's is partnering with a shawarma influencer to tell its story, and what's next for the menu and the concept. Subscribe on Apple Podcasts.Subscribe on Spotify.Menu Talk is a collaboration between Restaurant Business Senior Menu Editor Pat Cobe and Bret Thorn, senior food & beverage editor of Nation's Restaurant News. You can subscribe to it wherever you listen to podcasts.

If you have any prayer requests, we'd love to pray with you! Send your prayer requests to https://favor.church/prayer so our team can pray for you!__We love hearing testimonies because it helps build our faith! If you have a testimony to share, let us know at https://favor.church/testimonies__Is it your first time? We have a special gift waiting for you to welcome you to our family. We'd love to get to know you! Visit https://favor.church/imnew to know more!__Did you pray the salvation prayer? Best decision ever! You don't have to go through this faith journey alone. We'd love to tell you more about the decision and help you with your next steps. Please visit https://favor.church/isaidyes__️At Favor Church, we give with hearts that are grateful for what God has done for us. To give tithes and offerings, visit https://give.favor.church__Check out where we're doing church this week through our social media and website pages! To get more information, visit https://favor.church/checkitout__Want to sign-up for any of the events happening in Favor Church? Visit https://favor.church/manilanews to register__CONNECT WITH US:/ favor.mnl / favor.mnl / favor_church https://www.favor.church__#favorchurch#churchforimperfectpeople#thefamilyyouvebeenlookingfor

Welcome to The Business Influencer Podcast where we interview and explore the success stories of entrepreneurs, business leaders, senior policymakers and get insights from thought leaders around the issues of the day.In this episode, we sit down with Professor Hanifa Shah OBE to explore a remarkable career shaped by transformation, leadership, resilience and a willingness to think differently.Hanifa shares her perspective on what it really takes to drive transformation, challenging established ways of working, thinking outside the box and having the confidence to approach problems from a different perspective. She reflects on the experiences that have shaped her leadership journey, the importance of embracing change, and why some of the greatest opportunities can emerge when we are prepared to question conventional thinking.She also speaks candidly about the lessons she has learned along the way, the importance of resilience and staying true to your values. Throughout the conversation, Hanifa offers valuable insight into how leaders can navigate change, inspire new thinking and turn ideas into meaningful impact.Whether you're leading an organisation, navigating transformation, building your career or simply looking for a different way to approach challenges and opportunities, this episode offers an insightful perspective on leadership, innovation and the power of thinking beyond the obvious.Credits: Host - Ninder Johal DL Executive Producer - Narinder K. JohalAudio Editing - Simren Johal © Copyright by Nachural Publishing Our website: https://thebusinessinfluencer.co.uk & https://nachural.co.ukSubscribe for more podcasts!

"This Australian tour will remain unforgettable for me," says Shah Zaman Khan, son of legendary Pakistani singer Rahat Fateh Ali Khan, who is currently touring Australia alongside his father. Listen to an exclusive conversation with visiting singers as they reflect on the tour, music and their shared journey. - آسٹریلیا کا یہ دورہ میرے لیے ناقابلِ فراموش رہے گا، یہ کہنا ہے معروف گلوکار راحت فتح علی خان کے بیٹے شاہ زمان کا جو اس وقت اپنے والد راحت فتح علی خان کے ساتھ آسٹریلیا میں کنسرٹ ٹور پر ہیں۔ راحت فتح علی اور شاہ زمان سے ایس بی ایس اردو کی خصوصی بات چیت سنئے اس پوڈ کاسٹ میں۔Explore more ways to listen to the Urdu program here: Listen to SBS Urdu. Install our mobile app “SBS Audio” on Apple (iPhone) or Android devices: SBS Audio App. Download on the Apple App Store, Download on Google Play. Follow us on social media: SBS Urdu on Facebook and on SBS Urdu on Instagram. - ہر بدھ اور جمعہ کا پورا پروگرام اس لنک پرسنئے, اردو پرگرام سننے کے دیگر طریقے, “SBS Audio”کےنام سےموجود ہماری موبائیل ایپ ایپیل (آئی فون) یااینڈرائیڈ , ڈیوائیسزپرانسٹال کیجئے۔ ہمیں فیس بُک اور انسٹا گرام پر فالو کیجئے۔

If you have any prayer requests, we'd love to pray with you! Send your prayer requests to https://favor.church/prayer so our team can pray for you!__We love hearing testimonies because it helps build our faith! If you have a testimony to share, let us know at https://favor.church/testimonies__Is it your first time? We have a special gift waiting for you to welcome you to our family. We'd love to get to know you! Visit https://favor.church/imnew to know more!__Did you pray the salvation prayer? Best decision ever! You don't have to go through this faith journey alone. We'd love to tell you more about the decision and help you with your next steps. Please visit https://favor.church/isaidyes__️At Favor Church, we give with hearts that are grateful for what God has done for us. To give tithes and offerings, visit https://give.favor.church__Check out where we're doing church this week through our social media and website pages! To get more information, visit https://favor.church/checkitout__Want to sign-up for any of the events happening in Favor Church? Visit https://favor.church/manilanews to register__CONNECT WITH US:/ favor.mnl / favor.mnl / favor_church https://www.favor.church__#favorchurch#churchforimperfectpeople#thefamilyyouvebeenlookingfor

Shah Planning Action Against CJP? | Shri Krishna as Namazi | Yogi v Azam Khan | OCN, VN Bhatt

Hello, hello!

Intracerebral hemorrhage carries high morbidity and mortality, but growing evidence highlights meaningful opportunities for prevention, risk reduction, and long-term recovery. This episode covers key strategies, including blood pressure management, interpretation of neuroimaging markers, and individualized decisions around antithrombotic therapy. It also emphasizes the prolonged recovery timeline and the importance of a holistic, patient-centered approach to improving outcomes. In this episode, Casey S. Albin, MD, FAAN, speaks with Wendy C. Ziai, MD, and Vishank A. Shah, MD, coauthors of the article "Intracerebral Hemorrhage" in the Continuum® June 2026 Cerebrovascular Disease issue. Dr. Albin is a Continuum® Audio interviewer, associate editor of media engagement, and an assistant professor of neurology and neurosurgery at Emory University School of Medicine in Atlanta, Georgia. Dr. Ziai is a professor of neurology and critical care medicine at Johns Hopkins University School of Medicine in Baltimore, Maryland. Dr. Shah is an assistant professor of neurology and critical care medicine at Johns Hopkins University School of Medicine in Baltimore, Maryland. Additional Resources Read the article: Intracerebral Hemorrhage Subscribe to Continuum®: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Host: @caseyalbin Guest: @VishankShah3 Full episode transcript available here Dr Albin: A patient has suffered an intracerebral hemorrhage. They're taken to the neuro ICU, and they fortunately survive. But the journey does not end there. In fact, in some ways, the journey has just begun. Join us today as we unpack holistic care for ICH patients.  Dr Jones: This is Dr. Lyell Jones, Editor-in-Chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about earning CME, subscribing to the journal, and exclusive access to interviews not featured on the podcast.  Dr Albin: Hello to our audience. This is Dr. Casey Albin. Today, I'm interviewing Dr. Wendy Ziai and Dr. Vishank Shah about their article on intracerebral hemorrhage. This article appears in the April 2026 Continuum issue on cerebrovascular disease. Welcome to the podcast. I am so delighted that both of you are joining. To begin, let's just do a brief introduction of who you are and, and a little bit of how you got interested in the topic.  Dr Ziai: Hi, I'm Wendy Ziai. Thank you for having me on this podcast. I am a professor of neurology at Johns Hopkins. I am a neurointensivist, and I think I got primarily interested in this topic through clinical trials that I have been a part of since my fellowship days.  Dr Shah: Hi, everyone. I'm, uh, Vishank Shah. I am also, uh, very thankful for being invited to be a part of this podcast. I'm also a neurointensivist at Hopkins and the fellowship program director here for neurocritical care, and I'm interested in recovery after ICH, and that's why I'm a part of this work.  Dr Albin: Welcome to you both. It is such a treat for me to get to interview fellow neurointensivist, particularly those who have such a wealth of experience. So, I am delighted to dive into this. All right. So, to set the stage for our audience, intracerebral hemorrhage has long been approached with pessimism. But your article really highlights that there are meaningful advantages in prevention and risk stratification and long-term recovery for these patients. Though you both are neurointensivist, this article really emphasizes primary prevention and the holistic long-term care for the survivors. And so, to begin, Dr. Shah, can you just lay out a little bit for our listeners the scope of intracerebral hemorrhage and its community impact?  Dr Shah: Yeah. So, you know, ICH is the second most common type of stroke. There are more than three million new cases of ICH globally each year, and it accounts for thirty percent of all stroke types, but it is the one that has the highest mortality, with more than forty to fifty percent of the patients dying in the first thirty days, and then continued long-term impact on both functional as well as outcomes, as well as survivorship after the early period. And it also disproportionately impacts lower socioeconomic, and then minority races like Blacks, Asians, as well as Hispanic ethnicity. And so, there's a lot of work that needs to be done to reduce the burden of this disease.  Dr Albin: Absolutely. I mean, these can really be devastating for families, and I really am appreciative of your highlighting that there's a lot of disparities, and there's a lot of work to be done to really increase equity to these patients. I think a lot of this goes into really the AAN's focus on brain health and trying to improve some of what we're doing to maintain brain health. And I really wanted to kind of drill down on this because for ICH, there's a lot that can be done upfront as we think about how do we counsel patients who may walk into the office about strategies to prevent ever becoming an intracerebral hemorrhage patient. So, Dr. Shah, can you walk us through a little bit about what neurologists in the community need to be doing to make sure that no one ends up with us in the neurointensive care unit?  Dr Shah: Yeah, sure. So, I think, you know, one of the most important risk factors is, of course, hypertension and long-standing uncontrolled hypertension. And so really recognizing the need for early onset screening with regular blood pressure monitoring at a very early age, particularly in the races that I discussed earlier. And then I think another big part, obesity, metabolic syndrome, and type two diabetes. And I think there's a lot of interesting new work that with the GLP-1 agonist, you know, in a large multicenter cohort studies showing that patients receiving these had a significantly lower reduction risk of ICH. And so, this might be a really important part that, you know, clinicians need to start increasingly recognizing and using in their practice. And then, of course, other risk factors that are common include smoking, diet high in sodium, exposure to air pollution, both indoor as well as outdoor. And so, mitigating all of these risk factors can also reduce the burden of ICH.  Dr Albin: Absolutely. And I really want to highlight that hypertension plays such an important role and that we as neurointensivist, as community neurologists, really need to be creative about ways that we can help people meet those blood pressure target and meeting people in the community where they are, making sure that they're not suffering from side effects from their medication that would prevent them from sticking with it long term. Dr. Ziai, anything else to add about what we can do in the community?  Dr Ziai: So, we really want to emphasize, even in the acute phase, that patients moving forward need to have targeted interventions to reduce blood pressure, smoking, enhance their physical activity, have a diet that is high in fruits and vegetables and low in alcohol and salt, and then promoting weight loss, of course.  Dr Albin: And Dr. Ziai, I'm gonna ask you a little bit about one of the things that maybe not all of our listeners have heard about is this APOE2, APOE4 genetic risk for intracerebral hemorrhage. What's going on there and, and should clinicians be testing for that? Dr Ziai: That's a great question, and it is not one that we currently test people for at least acute ICH presentation. APOE2 and A4- E4 alleles, these give patients a two to three times higher risk of ICH by increasing cerebral amyloid deposition. And if you happen to have APOE2 carrier ship status, then along with other risk factors like white matter disease and vascular risk factors, these predict the onset of new microbleeds even during very short follow-up periods of about two years. And as we know, having cerebral microbleeds are associated with an increased risk of all strokes, ischemic and ICH, but they are one of many MRI markers of small vessel disease, which along with cortical superficial siderosis, does significantly increase future ICH risk. And so even in people who've never had an ICH, if they happen to have an MRI, it may be reasonable to look at the MRI and incorporate this burden of small vessel disease, and especially these hemorrhagic markers into, uh, decision-making about interventions.  Dr Albin: That's a really excellent point. And so, I think that your article did a really beautiful job of thinking holistically about the patient, incorporating clinical markers of their risk for having ICH, but also those radiographic markers. I'm just gonna ask you to summarize those again one more time because not everyone will be familiar with these. So, when you're looking at an MRI, what are the things that you're particularly clued in on that would increase the patient's risk of future ICH?  Dr Ziai: In the past, what we're looking for really is markers of cerebral amyloid angiopathy, which significantly increase a person's risk for lobar hemorrhage in particular. And so, we have a set of criteria called the Boston Criteria, and there's a new version of these, version 2.0. And these, um, incorporate a number of imaging markers that provide a very high sensitivity and specificity to diagnose CAA after an ICH. But even if someone's never had an ICH, and they evaluate that risk-benefit ratio for different cardiovascular prevention strategies. And so, the markers that we're specifically interested in are, of course, microbleeds. But not just having microbleeds, but are they lobar or are they deep? Lobar having a higher risk for lobar ICH. How many microbleeds are there? Is it greater than five, or is it just one or two? Also, cortical superficial siderosis is a marker, a hemorrhagic marker, that does portend a significant increased risk of recurrent ICH, along with having a lobar ICH. And now we have these new markers, which are the white matter hyperintensity multi spot pattern, which requires these hyperintensities on flare imaging in the subcortical area, having greater than at least ten of these multi spots, and also having enlarged perivascular spaces in the centrum semiovale, and having at least twenty of those. And finally, white matter hyperintensities, which can be measured with the physica score or just by visualizing them. We can look at white matter hyperintensities as well as being a measure of small vessel disease.  Dr Albin: Got it. And so just to summarize, we're looking for small vessel disease markers because that puts our patients at higher risk of ongoing future bleeds. And then we're also looking for markers of particularly small vessel disease that's caused by cerebral amyloid angiopathy, which again, because it's having that protein deposition, that puts the patient at risk of those leptomeningeal very small vessels, putting the patient at risk of lobar ICH. Just confirming I've summarized this all correctly.  Dr Ziai: Yes. That was perfect.  Dr Albin: Amazing. Dr. Shah, I'm gonna go back to you. Let's say we have a patient. Let's say this is a sixty-five-year-old man who comes in and they want follow-up and they're... And you're trying to think about they've had an ICH in the past, and they are also at risk for ischemic disease. Let's say they, they have hypertension, they've had a smoking history. They have some risk for ischemic events. And you're trying to think about how do you balance those. Let's say the patient needs to be on aspirin but does have some of those high-risk features on their MRI. Is there any guidance on how we think through preventing them from having a recurrent bleed if they're a high-risk patient, also preventing them from having an ischemic event, which they might be at high risk for as well?  Dr Shah: Yes. So, I think, you know, the first step is of course trying to understand what was the type of bleed. I think that has a very important role, like you mentioned. If it's a lobar hemorrhage versus a deep hemorrhage, the risk of recurrent ICH and ischemic events is very variable. So lobar hemorrhages, there's obviously a higher risk of recurrent hemorrhage events, whereas deep hemorrhage is actually at or behaves sort of like small vessel ischemic strokes and have a higher risk of recurrent arterial ischemic events. So that distinction in itself can help you gauge which patients would be safe and would benefit from these therapies. To begin, and of course, looking for some of these markers on MRI that were mentioned by Dr. Ziai for recurrence of hemorrhage risk. In terms of antiplatelet, the, there is a lot more data now to guide treatment, and we have the RESTART as well as the ESTART trial that showed that starting an, a single antiplatelet after intracerebral hemorrhage did not increase the risk of hemorrhage recurrence. They were very variable in the timing when aspirin was started, and so that remains still a question about what is the safest time point to start aspirin. For example, in the ESTART trial, they started them very early, within the first three days, whereas in  the RESTART it was all the way up to two months after the hemorrhage. And so... But in general, the risk of recurrent ICH was very low with a single antiplatelet agent. And so, if it's needed for ischemic prevention, it's relatively safe broadly across all types of hemorrhages.  Dr Ziai: Yeah. I would just mention that there was also a subgroup analysis of the RESTART trial using MRI. And so, this more than likely included patients with CAA, since 40% of the hemorrhages were lobar in that study, and therefore seeing that there was no increased risk of recurrent ICH in RESTART, it is thought that putting patients back on their antiplatelet therapy is safe.  Dr Albin: That's a really huge takeaway pearl for our listeners, that regardless of whether it's a lobar bleed or a deep bleed, if there is a strong indication, you know, this is not just, oh, because someone gave them aspirin 81, but truly that there is a reason that they need to be on a single antiplatelet agent, it probably benefits them to be on that agent, and there's good data that there's not a huge increase in risk. Summarizing all of that?  Dr Ziai: Great.  Dr Albin: Now, things are gonna get a little bit tricky here, because what if the patient, what if they need to be on dual antiplatelet therapy? Or what if they need to be on anticoagulation? Dr. Ziai, I'll, I'll throw that to you. How do you tackle that patient population?  Dr Ziai: Yeah, the safety of dual antiplatelet therapy hasn't really been studied in patients who've had a prior ICH. Although, in people who've had previous strokes, putting them on dual antiplatelets doesn't seem to increase the risk of ICH, but it does increase extracranial hemorrhage. And so there may be other reasons not to put patients on dual antiplatelet agents. Patients who have cancer and also cardiovascular or cerebrovascular disease, putting them on dual antiplatelet therapy does seem to increase the risk for intracranial hemorrhage. So, I think there is enough of a bias against DAPT therapy in patients who have had an ICH that we would not recommend DAPT for patients with a prior ICH.  Dr Albin: Absolutely. And, and then what about, let's say they have atrial fibrillation, and you know that they have a high CHA2DS2-VASc score, and they are at very high risk of ischemic events, but they've also had a prior intracerebral hemorrhage. Walk us through a little bit, how should we approach that patient? Dr. Ziai, I'm gonna start with you again.  Dr Ziai: Sure. So again, looking at the MRI, which all patients with ICH should have nowadays. If patients do have these hemorrhagic findings, a lobar ICH, evidence of CSS, cortical superficial siderosis, especially if it's disseminated, and also lobar microbleeds, especially if there are greater than five, if they're multiple, then anticoagulation should really be avoided in those patients.  Dr Albin: Absolutely. So, I'm really hearing that when we have a patient with ICH, it is just critically important that we understand is this a hypertensive bleed or is this a lobar bleed that is probably related to cerebral amyloid angiopathy? And getting to that distinction is going to play a major role in our deciding whether or not the patient can be on DAPT or can be on anticoagulation. And then what are some of the strategies for patients that you're referring them to if they really cannot tolerate being on anticoagulation, but they have atrial fibrillation, and they do need some sort of ischemic stroke prevention?  Dr Shah: There's still a lot of controversy, even in non-lobar hemorrhages, about resuming anticoagulation and when that would be safe. HAF trial, there was a reduction in ischemic stroke recurrence, uh, but a significantly higher increase in hemorrhage recurrences. I think that trial included both deep and lobar hemorrhages. So, we still need more data, and I think the ASPIRE trial and maybe a meta-analysis would answer that eventually. But in the meantime, if a, specifically for lobar hemorrhages, which are, uh, thought to be CAA related, if they, uh, and the patient has AFib, you know, where anticoagulation would be contraindicated, a watchman device or, you know, AFib ablation may be some of the other strategies that can be looked into for those patients specifically.  Dr Albin: Right. I think that's a really important point to emphasize, that we don't just don't give up and say, "Oh, you're not a candidate for anticoagulation," but we really reach out to our cardiovascular friends and say, "Hey, what other procedures can you offer that will minimize the risk of recurrence?" You know, we don't want them to have an ischemic event, but we also know long-term that there would be a real risk of anticoagulation. Just reminder to our listeners that there are new procedures, and our cardiology colleagues are always doing new trials and new devices, and so we should really leverage their expertise here. I am in the final minutes gonna just switch gears a little bit from talking about sort of the nitty-gritty of secondary ischemic prevention and secondary hemorrhagic stroke prevention and thinking about there has been this degree of pessimism around ICH patients, and that, you know, they have a much more severe outcome than our patients with ischemic strokes. I think that that is probably a myth that we need to do some debunking around, and I think maybe we need to reframe in terms of thinking about just the trajectory. So, Dr. Shah, walk us through a little bit about what we can expect about the recovery trajectory in ICH compared to those patients who have an ischemic stroke. Dr Shah: Yes. From some newer data and studies, it is becoming clear that recovery after ICH is much slower than we expect. In general, for ischemic stroke, recovery is measured within the first few weeks to up to 90 days. But in ICH, we now know that patients can keep recovering all the way up to six months and even beyond. In general, from just a, a study of heart recovery that occurs after ischemic stroke, there's a steep recovery in the first seven days, and then sort of after that, patients still continue to recover, but it, it starts plateauing where up to 90 days. Whereas with ICH, there is not much recovery in the first 7 to 30 days, but after that, there is a recovery that occurs significantly between day 30 and day 180, and then some patients continue to recover all the way up to one year. The more severe the hemorrhage, the slower the recovery, but there's still some evidence to suggest that even severe hemorrhage patients can recover all the way up to one year out and beyond. This is, of course, in terms of functional recovery.  Dr Albin: I think that's a really important point for our audience. Many of the listeners are residents, they're fellows, they're seeing these patients in the hospital, and they may not see a whole lot of improvement over even 30 days. But to keep in mind that just because the patient has not had a dramatic recovery within that first month that they may be in the ICU and then on the floor does not mean that that patient will never have recovery, and that we reset our expectations that recovery is possible, it's just gonna be slower. And I think that that's not only important for the healthcare team to take in mind, but also for patients and their families to know there is hope here. It's just gonna be slower. Dr. Ziai, looking ahead, what developments in this are you most excited about that you think will move the needle for care for the long-term outcomes and the prevention for these patients? What's ahead in, in ICH?  Dr Ziai: Yeah, I think the research that's going on is very exciting at the moment. We just saw the presentation at the World Stroke Organization conference in the fall of the TRIDENT trial, Triple therapy prevention of Recurrent intracerebral Disease events, meaning strokes. And these investigators found that a single pill, a fixed dose of three blood pressure-lowering agents actually was successful in significantly reducing the risk of recurrent stroke in patients who have had a history of ICH and have just normal or low-grade hypertension. So rather than having patients on multiple antihypertensive agents, it may be possible to have them on a single pill, and may dramatically reduce their stroke risk. So that's exciting. There is also a trial ongoing, ASPIRING, testing whether antiplatelet monotherapy after 24 hours only can reduce the risk of all serious vascular events in ICH survivors. So very early antiplatelets. The SATURN trial, we didn't talk about statins yet, but it is comparing continuation versus discontinuation of statin therapy in ICH patients. And then we have ongoing epidemiological studies that are really needed to understand this interaction between the cardiovascular prevention strategies, the antithrombotic use, the blood pressure targets, and these high-risk neuroimaging markers for ICH. And I think that's gonna be key, personalizing the interventions for these patients.  Dr Albin: So, I love that. And what I'm hearing is that it's really important to think about the personalized approach as well as how do we simplify things. We know that blood pressure control is critically important to the primary and secondary prevention of ICH, but we have to make it easy for patients to do so. Dr. Shah, I want to end with kind of understanding, you know, this was an unusual topic for neurointensivists to talk about. This was really about prevention. It was about long-term survivorship. It was about not what's happening in the neuro ICU. How did you guys get interested in sort of that aspect of care?  Dr Shah: Yeah, so that's a great question. Dr. Ziai has been my mentor since I was in fellowship, so now about eight years that I've been working with her, and this was a project that I started in fellowship with under her mentorship, looking at long-term recovery in ICH patients, and specifically severe patients. Happy that work has received a lot of recognition. It was published in JAMA Neurology. We looked at patients with severe intracerebral and intraventricular hemorrhage, those that survived with an mRS of four and five at day 30, and what happened to them over the course of the year. There was really not much data on recovery after ICH. And we were very surprised to see that up to 40% of patients that were an mRS of four and five, so really, really severely disabled at day 30, recovered to an mRS of zero to three by one year. About one-third of that group that recovered actually achieved functional independence with an mRS of zero to two, which was very surprising, really breaking the myths around the pessimism with ICH. We found that a lot of the baseline comorbidities like diabetes, white matter disease, as well as what happens to them during the acute hospitalization, were adding all of that information to the severity of the hemorrhage significantly improved our ability to predict long-term recovery after ICH. And so that's kind of how we got interested in this work, looking at how factors in the care that we provide in the ICU, as well as what the patients come in with, how all of that could be modified to promote recovery in these patients that are often been forgotten.  Dr Albin: I think that there's one takeaway to our listeners is that this is really a place where there's a lot of hope for recovery, and that the nihilism that has really surrounded ICH is a thing of the past, and we have to move forward with thinking about how do we proactively impact the recovery and counsel the patients and give them hope. Because just as your research shows, there really is the ability that they can attain that functional independence, which is absolutely astounding. It's really amazing. Again, today I've been interviewing Dr. Wendy Ziai and Dr. Vishank Shah about their article on intracerebral hemorrhage. This article appears in the April 2026 Continuum issue on cerebrovascular disease. Please be sure to check out Continuum Audio episodes from this and other issues. Please go and check out. They have a wonderful article with lots of tables and figures, so much data. And again, thank you to our listeners for joining us today. Thank you, Dr. Ziai and Dr. Shah.  Dr Ziai: Thanks very much.  Dr Shah: Thank you.   Dr Monteith: This is Dr. Teshamae Monteith, Associate Editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use the link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at continpub.com/audioCME. Thank you for listening to Continuum Audio.

Bassist Tarik Shah is hosting jam sessions on Monday nights at Lark Tavern from 7-9pm. Fellow bassist Brad Monkell interviewed Tarik about what makes a good jam session, the importance of musicians communicating with each other, and his way with the bass.

Cred just reported its first profitable quarter. Meta invested 8,500 crore rupees. And Kunal Shah walked out the door.Eight years of questions about Cred's business model ended the moment it finally had answers. The design-first, exclusivity-obsessed fintech that rewarded creditworthy Indians with gold credit cards now makes most of its money from lending — the same way every other UPI app does.Shah left for WhatsApp. Meta needed someone who could monetise a billion Indian users without making regulators nervous. What that means for both companies is the more interesting question.Scripted by Snigdha Sharma based on the report by Suprita Anupam.Daybreak is produced from the newsroom of The Ken, India's first subscriber-only business news platform. Subscribe for more exclusive, deeply-reported, and analytical business stories.

On Monday's Mark Levin Show, Senator Lindsey Graham, a loyal friend and loyal ally to democratic and peace-loving countries around the world, has passed away. He was a friend to Israel, Ukraine, Taiwan, and others. He was a counterbalance to naive Woke Reich isolationists who talk about American sovereignty but don't realize you have to fight for it. Graham had a lot in common in national security matters with Ronald Reagan. Not even a nation as powerful as the United States can go it alone, and Graham understood we have alliances for a reason. Marxists/Islamists like Hasan Piker and Woke Reich isolationists wasted no time attacking him, but he was popular in South Carolina and all over the world. He and his sound advice will be truly missed. Also, compare Graham's friendship with Israel to Rep Ro Khanna, who took it upon himself to visit Judea/Samaria, incorrectly called the "West Bank." Khanna didn't bother telling the IDF or police, but he did go with Palestinian activists and NY Times reporters with cameras for good measure. Khanna claims he was "kidnapped" by Israeli "settlers" -- another wrong term, how can you settle on your own indigenous land? -- detained by police and mistreated by the IDF. Video shows Khanna is a liar. Why did he do all this? One, to build support for himself among Jew-hating left wingers and also to defeat Benjamin Netanyahu in Israeli elections. Israel needs friends like Lindsey Graham. Then, we can criticize a document without criticizing the President, who is doing a wonderful job. Trump said he only agreed to the MOU as a "test." The MOU never made sense because this regime was never going to live up to it. Why go through all this for a test? As much as we want to believe a deal can be negotiated, you can't negotiate with a seventh-century ideology. If we don't take this regime out now, our children and grandchildren will still be dealing with them. Also, former Iranian President Mahmoud Ahmadinejad has been arrested reportedly over ties to Mossad. According to reports, Mossad wanted him to possibly lead a new Iranian regime. Another report says Israel has signed an agreement with the son of the Shah of Iran, Crown Prince Reza Pahlavi, recognizing him as leader of a new Iranian government. It's clear that Israel isn't waiting around to see if any MOU will take effect. Then, there are a lot of mosques in this country that preach anti-American hate, and many of them are celebrating Lindsey Graham's death. But these mosques have a lot of sympathy. A new survey shows almost half of American Muslims - 44% - support Hamas. Only 26% of American Muslims have a favorable view of Israel. Support for Israel is even dropping among younger Republicans. Is Israel losing the PR war among Americans? Finally, Abdul El-Sayed is the left-wing Marxist/Islamist running for the Senate from Michigan. He pushes Medicare for all from cradle to grave, yet his psychiatrist wife doesn't accept Medicare...or any other insurance. Her patients have to pay her out of their own pocket. Furthermore, while El-Sayed hasn't released his tax returns, we find out he and the wife are wealthier than when he first ran for statewide office, and he owns two rental properties worth almost a million dollars. The hypocrisy of the left has to be seen to be believed. Learn more about your ad choices. Visit podcastchoices.com/adchoices

In this episode of The Iran Podcast, Negar Mortazavi speaks with Sina Azodi about his book, Iran and the Bomb, tracing the history of Iran's nuclear program from its origins under the Shah through the 1979 revolution, the Obama-era JCPOA, Trump's maximum-pressure campaign, two wars, and the uncertain state of the program and diplomacy today.This live conversation was recorded at Busboys and Poets in Washington. (Part 1)

In this episode of The Iran Podcast, Negar Mortazavi speaks with Sina Azodi about his book, Iran and the Bomb, tracing the history of Iran's nuclear program from its origins under the Shah through the 1979 revolution, the Obama-era JCPOA, Trump's maximum-pressure campaign, two wars, and the uncertain state of the program and diplomacy today.This live conversation was recorded at Busboys and Poets in Washington. (Part 2)

Send us Fan MailDermatologist Dr. Muneeb Shah returns to Skin Anarchy to break down what actually works in skincare, how GLP-1 medications affect the skin, the truth about trending ingredients, and how to spot credible science communication online. Below are the biggest questions answered in this episode.Why did Dr. Muneeb Shah start his own skincare brand, Remedy?After years of educating patients one at a time in clinic and then millions online, Dr. Shah saw a gap between how dermatologists actually treat skin and how most products are formulated. Remedy was built to combine multiple ingredients backed by evidence into single formulas, control ingredient sourcing, and remove emerging allergens as the science evolves. He frames it as the natural next chapter of his work: "Content was a hill at one point, and this is my new hill... building a brand that really becomes a legacy brand."Why do so many skincare products feel identical?Because many of them are. Dr. Shah explains that contract manufacturers offer white label stock formulas, so any brand with capital and distribution can put its label on an existing product and launch it. "It's not hard to launch products if you have the capital and the distribution network to support it," he says. "It's hard to launch good products." When an ingredient trends, brands rush to license the same stock formula, which is why the market floods with nearly identical products around every viral ingredient. Remedy's policy is to never use white label formulas and to start from a patient need rather than a trend.Which skincare ingredients are actually backed by science?According to Dr. Shah, the strongest evidence still sits with the tried and true ingredients: retinoids like retinol and tretinoin, alpha hydroxy acids like glycolic acid, select peptides but not all of them, ceramides for the skin barrier, niacinamide, and azelaic acid. His formulation philosophy anchors everything around these proven actives first, with marketing layered on only afterward, never the reverse. "The products have to be really great products that people will use forever, and they have to use ingredients that truly have the efficacy studies on them."Is PDRN worth the hype?Dr. Shah does not dismiss PDRN, noting it has real traction in East Asia, where dermatologists champion it, particularly in injectable form. "I'm not saying that doesn't have validity or evidence. Time will tell if this is something that stands the test of time." His caution is about how trends work: brands slap labels on stock PDRN formulas to ride the moment, and an ingredient trending is not the same as an ingredient being proven.What does "next generation biomimetic surfactant technology" actually mean?Usually nothing. Dr. Shah points out that "they're using the same surfactants everybody's got in their formulas... no one's inventing new surfactant technologies." Terms like this are marketing language designed to make a formula seem more advanced or worth a higher price, and even sophisticated consumers fall for it because there is not enough public knowledge about what these formula components actually do.What do GLP-1 medications like Ozempic do to your skin?Rapid weight loss from GLP-1 medications can outpace the skin's ability to retract, leading to crepiness, laxity, and undulations where fat volume was lost beneath otherwise healthy skin. Dr. Shah notes dermatologists saw similar effects with gastric bypass, but it was rare enough that it never needed a name. That is no longer the case: "Now that it's 12 percent of the population, we have to really contend with this."What skincare should you use while on a GLP-1?Dr. Shah recommends topicals that support collagen throughout the weight loss period: a retinoid such as retinol or tretinoin, an alpha hydroxy acid like glycolic acid to stimulate collagen production, and peptides with collagen evidence such as Matrixyl. "Anything that's gonna support your collagen and elasticity, maybe even like a copper peptide due to the elasticity element of the skin." These support the epidermis and dermis, but he is clear that topicals alone cannot compensate for significant fat and muscle volume loss underneath.Can loose skin from GLP-1 weight loss be fixed?Sometimes it resolves on its own if weight loss is gradual, but Dr. Shah notes many patients are started on doses that are too high. "When you lose 30 pounds in a month, there's really no skin treatment that can account for that loss of weight to make your skin snap back." For skin that does not recover, professional options include lasers, deeper chemical peels, and in some cases filler around bony structures to restore support. Slower weight loss gives the skin the best chance to keep up.Why does nutrition matter so much on a GLP-1?Because appetite drops sharply, patients risk falling short on protein and essential nutrients during a period of significant muscle and fat loss. "Anyone that's on a GLP really needs to optimize their nutrition while they're on it," Dr. Shah says, "because you're eating less, but what you're eating really then matters." He argues nutrition is a layer dermatologists need to be discussing with every GLP-1 patient, ideally in collaboration with nutritionists, gastroenterologists, and weight loss specialists rather than working in silos.Do GLP-1s cause immune reactions?"A lot of people actually develop antibodies to GLPs... your body recognizes it's a foreign invader and tries to neutralize it," Dr. Shah explains, which can produce injection site reactions, fevers, muscle aches, or symptoms that feel like the flu after injecting. This immunologic layer is rarely discussed, and he draws a parallel to PD-1 inhibitors in oncology, where he and Dr. Maxfield published an early case report of a patient developing type 1 diabetes from the immune system attacking the pancreas, a side effect now well documented in the literature.Are chemical sunscreens safe?Dr. Shah personally wears chemical sunscreens and prefers how they look on his skin, but he refuses to speak in absolutes in either direction. The data shows chemical filters absorb into the body more than previously thought, and no one yet knows whether that matters. At the same time, no study has shown actual harm in people, which is why they remain on the market. "To absolutely say these are completely safe and nothing bad will ever happen to you, that's a dangerous absolute to live in, in my mind."Is longevity just antiaging rebranded?Largely, yes, in Dr. Shah's view: "Longevity is really just similar to antiaging and to bodybuilding in the sense that it's a more extreme form of maximizing your health." He compares it to how looksmaxxing extended bodybuilding culture to the face, the same pursuit taken further. What has changed is access. Anyone can now watch a billionaire biohacker's routine on YouTube and order peptides from a telehealth site, which is exactly what makes this moment both exciting and precarious.Are injectable peptides from telehealth sites regulated?Not in the way most consumers assume. "I'm excited about the technology that's coming out as a scientist," Dr. Shah says. "As a doctor, I'm nervous about the access and lack of regulation." He predicts a regulatory correction, whether imposed by government or by the industry itself, after enough people experience negative consequences from unvetted peptides and unregulated med spas. He expects consumers will eventually start asking where products come from, seeking FDA approved options, and vetting the credentials of anyone treating them.What is the danger of telehealth prescribing without integrated care?Dr. Shah gives the example of someone with hair loss who researches online, requests minoxidil, finasteride, or spironolactone through a telehealth platform, and receives it at their door. "Turns out they have thyroid disease. No one asked the question... this element of integrated medicine is being completely removed." As telemedicine grows, conditions get treated at the surface while underlying diagnoses are missed entirely.How do you know which skincare experts to trust online?Dr. Shah's rule: be wary of anyone who speaks in absolutes. "When you speak in absolutes, most of the time you're gonna be wrong because there's not enough information out there." On polarizing topics like parabens, fragrance, or chemical sunscreens, both the "completely safe" and "completely toxic" camps overstate what the evidence supports. Trustworthy communicators caveat their claims, resist being first to react before information is complete, and publicly correct themselves when new data proves them wrong. He cites the erosion of trust in medicine during COVID as the cost of premature certainty.Listen to the full episode with Dr. Muneeb Shah on Skin Anarchy, available wherever you get your podcasts.Shop Remedy SkinDon't forget to subscribe to Skin Anarchy on Apple Podcasts, Spotify, or your preferred platform.Reach out to us through email with any questions.Sign up for our newsletter!Shop all our episodes and products mentioned through our ShopMy Shelf!Support the show

Captain Christopher Behnam's story is one of survival, perseverance, and proof that dreams CAN come true for anyone bold enough to dream and work for them. As a child, Capt. Behnam's family suffered greatly under the Iranian regimes of the Shah and Islamic Republic. Yet, he managed to hold on to the dream of flight and eventually make his way to the United States. Through an arduous aviation journey of ups and downs, he eventually reached the cockpit of the Boeing 777. And yet, is greatest test was yet to come when the United 777 he was commanding over the Pacific had a catastrophic engine failure that simulators had never planned for. Through the collective work of Captain Behnam, First Officer Paul Ayers, and jump seat pilot Ed Gagarin, the crew managed to land the aircraft and save the 381 people on board. Hear his amazing story! Save up to 5% on Your AVEMCO Aircraft Insurance when you mention "SocialFlight"!“SocialFlight Live!” is a live broadcast dedicated to supporting General Aviation pilots and enthusiasts during these challenging times. Register at SocialFlightLive.com to join the live broadcast every Tuesday evening at 8pm ET (be sure to join early because attendance is limited for the live broadcasts).SocialFlight Partners: Avemco Insurance https://www.avemco.com/socialflight Aspen Avionics https://www.aspenavionics.com Avidyne https://www.avidyne.com Continental Aerospace Technologies https://www.continental.aero EarthX Batteries https://www.earthxbatteries.com Hartzell Engine Technology https://www.hartzell.aero Hartzell Propellers https://hartzellprop.com/Innovative Aerosystems https://iascorp.com/Lightspeed Aviation www.lightspeedaviation.com Michelin Aircraft https://aircraft.michelin.com/ Phillips 66 Lubricants https://phillips66lubricants.com/industries/aviation/ Tempest Aero https://www.tempestaero.com Trio Avionics https://www.trioavionics.com uAvionix https://www.uavionix.com Wipaire https://www.wipaire.com

LET'S MAKE IT A BLOCKBUSTER NIGHT, 80min., USA Directed by Amir Shah An Italian-American foreign language instructor and aspiring actress auditions for a role in a German lollipop commercial. An Iranian actress auditions for the same role. Little do both actresses know, that this German TV production company and the lollipop commercial casting , is not really what it seems . —— Subscribe to the podcast: https://twitter.com/wildsoundpod https://www.instagram.com/wildsoundpod https://www.facebook.com/wildsoundpod —— Love for you to try the Indy Film Festival AP. • Daily new film festival of the best new films from around the world. New archived festival to watch anytime. • Library of over 500+ award-winning films to watch anytime. Go to https://www.wildsound.ca and sign up for the free 3-day trial. Check out the daily film festival (and previous ones from last month) at https://www.wildsound.ca/browse Always an amazing lineup of films. Inspiring for storytellers.

What are Modi's - Shah's Big Plans? | Ram Mandir Impact on Yogi | NCP Joining NDA? | Bhau Torsekar

Jason gives you a quick overview of the events in Iran leading into and during the Second World War.Read the essay here: https://historywiththeszilagyis.org/hwts287Find us on the socials:The Network: @BQNPodcasts The Show: @HistorySzilagyi. Chrissie: @TheGoddessLivia.  Jason: @JasonDarkElf.History with the Szilagyis is supported by our patrons: PatiSusan Capuzzi-De ClerckLaura DullKris HillBetty LarsenVince LockeJoin these wonderful supporters by visiting patreon.com/historywiththeszilagyis. BQN Podcasts are made possible by the generous contributions of listeners like you. We extend our heartfelt gratitude to our Patreon patrons, whose support has been instrumental in producing the network!Chad RidingMei M G. Haukur GuðmundssonJax Cordd Daniel EvansLars Di ScenzaWilliam J. JacksonJonathan SnowJerry AntimanoSusan L. De ClerckMatt HarkerDavid WillettCarl WondersPeter HongTom Van ScotterJim McMahonThad HaitChristina De Clerck-SzilagyiPatreon User

Graham Platner is out… but is he? Last night in Maine, he released an 11-minute video that savaged the Democratic establishment and the progressive establishment. He blamed everybody but himself for why he's suspending his campaign, saying all of his resources were taken away from him. The people who didn't fight for him — Ro Khanna, Bernie Sanders, Hasan Piker — all wound up in the blast radius.Everybody wanted Platner to be a lot more conciliatory. He was not. He was forceful. He took what he wanted. But here's the big question: you can't declare bankruptcy like Michael Scott. You can't just walk into the office and yell, “Bankruptcy.” You need to file paperwork. So even though Graham Platner suspended his campaign on Twitter, that doesn't mean his campaign is suspended in real life.Politics Politics Politics is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.He's telling people he'll suspend his campaign on Monday. By the way, Monday is when he needs to file by. If Graham Platner gets a little sleepy on Monday and forgets to file, then there's no replacement. He's the nominee. That's something to keep an eye on. Now, full transparency: I don't believe he's going to do that. I do believe he's going to file either then or sooner, and this will eventually blow over. But, still, with this guy, you really never know.So the question becomes: who's running against Susan Collins? A handful of names are now in the mix, and they'll essentially be decided at a hastily thrown together state convention sometime in the next few weeks, because Democrats need an answer by July 27th. Troy Jackson tends to be more of the favorite of the progressives. Nirav Shah, the former Maine CDC director, is in the conversation. Dan Kleban, who had initially been running against Platner before dropping out when Janet Mills got involved, is back in a big way. Jordan Wood, Paige Loud, and Shenna Bellows bring up the rear.I don't know exactly what happens at that convention. Are they all going to debate on one stage? Are they just going to make their pitches and then have a back and forth? I do know this: if you leave it up to the supporters of those people, they're going to start knifing each other. And if you're a Democrat trying to take down Susan Collins, that's the last thing you want. You don't want this to get fractious.There's some polling from a pro-Nirav Shah outside group showing Shah up on Collins 47-46, Collins up on Troy Jackson 48-47, and Collins tied with Shenna Bellows 47-47. I don't know whether that's a reputable outfit or whether those are reputable polls. What I'll say is this: if you're tied with Susan Collins, you're losing. Platner, before the disaster, was running about eight to ten points ahead of Susan Collins. Now Democrats are looking at people who are tied, and Susan Collins regularly outperforms her polls by six to eight points. So if you're tied with Susan Collins, you're losing. Have we seen the last of Graham Platner? Man, I really don't know.Chapters00:00 - Intro03:52 - Graham Platner09:47 - Trump's Plane Switch12:40 - Mexico, ICE, and Dems Polling18:55 - Interview with Juliegrace Brufke52:36 - Wrap-up This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.politicspoliticspolitics.com/subscribe

Shah & Jon are back to discuss the following:The World Cup fall out and the U.S. elimination.Evil Dead: Burn (Early Reviews and Predictions)NEON's Hope might be the best trailer of the year. & MORE! 

In this month's episode of Energy Transition Today, we sit down with Minesh Shah, the managing director at InfraRed Capital Partners and Chris Sweetman, the chief operating officer at The Renewables Infrastructure Group (TRIG)* to talk about onshore wind repowering in Europe.Shah lays out the financial considerations for onshore wind repowering and the variables that influence TRIG's decision to repower an asset.Sweetman, on the other hand, lays out the technical and permitting complexities associated with repowering and debunks some of the assumptions made about the process.We also discuss the need and opportunities for onshore wind repowering in Europe as well as the influence of policy and revenue streams on investors' appetite for this asset class.[*InfraRed Capital Partners is the designated investment manager of TRIG.]Reach out to us at: podcasts@inspiratia.comFind all of our latest news and analysis by subscribing to inspiratiaFor tickets to our events email conferences@inspiratia.com or buy them directly on our website. Listen to all our episodes on Apple Podcasts, Spotify, and other providers.  Music credit: NDA/Show You instrumental/Tribe of Noise©2025 inspiratia. All rights reserved.This content is protected by copyright. Please respect the author's rights and do not copy or reproduce it without permission.

He turned 50, watched his energy crash, and instead of reaching for a pill, he threw out cooked food entirely — 16 years later he's run eight marathons and never taken a single medication.Axay Shah, author of "In Nature We Trust," joins Brigitte to explain why he ditched cooked food at 50 and hasn't looked back. His philosophy is simple: if Mother Nature didn't make it, it doesn't go on his plate. No more diabetes, no blood pressure issues, no doctor visits — just raw fruits, vegetables, and a mantra he built his life around. Brigitte and Axay swap notes on food intolerances, the myths around dairy and calcium, and why listening to your body beats listening to marketing.3 Takeaways:(1) Energy dips aren't always "just aging" — sometimes it's what's on your plate.(2) Pain and soreness aren't the enemy; they're your body asking for repair, not a painkiller.(3) You are the one responsible for your health — not your doctor, not your parents, not your spouse.Curious if raw living could work for you? Grab Axay's book "In Nature We Trust" on Amazon, or reach him directly at https://rawfoodiest.com

Industrial Talk is onsite at Xcelerate 2026 and talking to Nisarg Shah, Maintenance/Planner Engineer at Martinrea International about "eMaint platform deployment". Overview Nisarg Shah, a maintenance planner at Martinrea, discussed his experiences with Fluke's eMaint software at the Xcelerate 2026 event. Initially, the challenge was getting employees to use tablets for data entry. Nisarg overcame this by daily encouragement and teaching. The next challenge was integrating eMaint with the existing email system to automate data collection. They now focus on pulling data directly from PLCs, including temperature readings and cycle counts. Nisarg highlighted the benefits of meter-based PM, which significantly reduced breakdowns. He also mentioned using acoustic imaging for leak detection, saving money on maintenance. Outline Fluke's Xcelerate Event Overview Scott introduces the Industrial Talk podcast, sponsored by Fluke, highlighting the Xcelerate event in Austin, Texas.The event featured high-energy keynotes, hands-on predictive maintenance tools, and breakthrough AI diagnostics.Xcelerate proved to be a launch pad for smarter, faster, and more reliable operations.Listeners are encouraged to visit fluke.com for more information. Introduction to Nisarg Shah and His Role Scott welcomes Nisarg Shah, a maintenance planner at Martinrea, a tier-one supplier to the automotive industry.Nisarg started with Martinrea as a student at the University of Windsor, where he worked on deploying eMaint at the facility.Nisarg has been with the company for four years, and the company has been in operation for about 30 years.The company specializes in stamping and welding, and Nisarg is responsible for implementing and managing eMaint. Challenges and Implementation of eMaint Nisarg faced challenges in getting employees to use tablets for data entry, as they were not tech-savvy.The initial challenge was convincing employees to enter data accurately, which was previously done via email.Nisarg addressed the issue by continuously teaching and pushing employees to enter data correctly.The company needed a better way to manage assets and prevent breakdowns, leading to the implementation of eMaint. Integration and Data Collection Nisarg discusses the next challenge of integrating eMaint with the existing email system to collect better data.The goal is to get direct data from the PLCs instead of manual data entry.The company is currently working on integrating temperature readings, cycle counts, and PM calendars.Plans include installing vibration sensors and thermocouples on a new 3000-ton press to collect more comprehensive data. Impact of AI and Advanced Technologies Nisarg is impressed by the AI version of eMaint , which can build on existing data to provide more accurate predictions.AI can help in quickly accessing manuals and specific pages, reducing the need to scour through lengthy documents.The company is also using acoustic imaging to detect leaks, saving money on maintenance.Nisarg highlights the benefits of using AI and advanced technologies to improve operational efficiency and reduce downtime. Benefits of Meter-Based PM Nisarg emphasizes the effectiveness of meter-based PM, which helps in predicting and preventing breakdowns.Meter-based PM allows for better data collection and analysis, leading to improved asset management.The company has seen significant improvements in reliability and reduced downtime by using meter-based PM.Nisarg recommends integrating all assets with eMaint to achieve even better results. Conclusion and Contact Information Nisarg shares his contact information, inviting listeners to connect with him on LinkedIn.Scott thanks Nisarg for sharing his experiences and insights on the podcast.The podcast wraps up with a reminder to visit fluke.com for more information on Fluke's solutions and services.Speaker 1 encourages listeners to tell their industrial stories and stay engaged with the Industrial Talk podcast. If interested in being on the Industrial Talk show, simply contact us and let's have a quick conversation. Finally, get your exclusive free access to the Industrial Academy and a series on “Why You Need To Podcast” for Greater Success in 2026. All links designed for keeping you current in this rapidly changing Industrial Market. Learn! Grow! Enjoy! NISARG SHAH'S CONTACT INFORMATION: Personal LinkedIn: https://www.linkedin.com/in/nisarg-shah-475395128/ Company LinkedIn: https://www.linkedin.com/company/martinreainternational/ Company Website: https://www.martinrea.com/ PODCAST VIDEO: https://youtu.be/pP6IU-m4eaA THE STRATEGIC REASON "WHY YOU NEED TO PODCAST": OTHER GREAT INDUSTRIAL RESOURCES: NEOM: https://www.neom.com/en-us Hexagon: https://hexagon.com/ Arduino: https://www.arduino.cc/ Fictiv: https://www.fictiv.com/ Hitachi Vantara: https://www.hitachivantara.com/en-us/home.html Industrial Marketing Solutions:  https://industrialtalk.com/industrial-marketing/ Industrial Academy: https://industrialtalk.com/industrial-academy/ Industrial Dojo: https://industrialtalk.com/industrial_dojo/ We the 15: https://www.wethe15.org/ YOUR INDUSTRIAL DIGITAL TOOLBOX: LifterLMS: Get One Month Free for $1 – https://lifterlms.com/ Active Campaign: Active Campaign Link Social Jukebox: https://www.socialjukebox.com/ Industrial Academy (One Month Free Access And One Free License For Future Industrial Leader): Business Beatitude the Book Do you desire a more joy-filled, deeply-enduring sense of accomplishment and success? Live your business the way you want to live with the BUSINESS BEATITUDES...The Bridge connecting sacrifice to success. YOU NEED THE BUSINESS BEATITUDES! TAP INTO YOUR INDUSTRIAL SOUL, RESERVE YOUR COPY NOW! BE BOLD. BE BRAVE. DARE GREATLY AND CHANGE THE WORLD. GET THE BUSINESS BEATITUDES! Reserve My Copy and My 25% Discount

Harshad Shah learned early on that giving back isn't something you do once you're successful, it's just something you do.  In this episode, Harshad shares what it was like growing up the youngest of 11 in post-independence India, how he didn't plan to stay in America but a one-month visit to Chicago changed his mind, and how a $30,000 lab in his garage grew into Hamilton Plastics and a portfolio of other businesses. Harshad Shah is the President and CEO of Hamilton Plastics. You can connect with him on LinkedIn (https://www.linkedin.com/in/harshad-shah-9aa4b722/).  If you like this episode, we think you'll also like: Dr. Elaine Swafford's Morning Cup (E64) Keith Sanford's Morning Cup (E86) Hamp Johnston and Camille Daniel's Morning Cups (E159)  Subscribe to the weekly newsletter and be the first to know who upcoming guests are: http://eepurl.com/iGJzII  My Morning Cup is hosted by Mike Costa of Costa Media Advisors and produced by SpeakEasy Productions.

Subscribe now for an ad-free experience. Sina Azodi, assistant professor of Middle East politics and director of the Middle East Studies program at George Washington University, returns to the show to talk about Iran's nuclear program. The group discusses the Shah's nuclear agenda, Atoms for Peace, Iran's signing of the Nuclear Non-Proliferation Treaty, how the Iran-Iraq War influenced Iran's nuclear policy, missed opportunities for diplomacy after 9/11, Trump's withdrawal from the JCPOA and why Biden didn't revive the deal, and the recent war with Iran. Grab a copy of Sina's book Iran and the Bomb: The United States, Iran, and the Nuclear Question. And contribute to GiveDirectly's campaign to help survivors of the earthquake in Venezuela. Note: In lieu of a news episode this week, we will be posting an interview about the holiday. Learn more about your ad choices. Visit megaphone.fm/adchoices

Welcome back to the WHOOP Podcast How To Series! This week, Global Head of Human Performance Principal Scientist Dr. Kristen Holmes sits down with double-board certified physician, nutritionist, and gut health expert Dr. Amy Shah to teach you how to fix your gut through nutrition and lifestyle behaviors. Gut health is essential for energy, recovery, and immunity, making it a critical component for overall health and longevity. Dr. Shah reveals the powerful connection between gut health, hormones, and brain function, along with the tools and framework you need to impact your overall performance. The conversation dives into science-backed strategies to help optimize your health from the inside out. From fiber intake to morning sunlight, meal-timing, and movement, this episode will teach you how to fix your gut health in a matter of days.(01:01) Introducing Dr. Amy Shah, Gut Health Expert(02:56) Dr. Shah's Career: (10:43) What Is The Gut-Brain Connection?(15:21) Where To Start When You Experience Low Energy(21:07) Exclusive Offer For WHOOP Podcast Listeners(21:40) The Universal Rules of Gut Health(24:36) The 30-30-3 Diet: The Nutrition Guide For Your Gut(30:18) Exercise's Influence on Gut Health(35:11) Fiber: The Secret Ingredient To Longevity(37:23) How The Gut Helps Hormone Regulation(38:14) Protecting The Immune System(43:17) Refer A Friend To WHOOP(43:54) Reducing Inflammation (And How WHOOP Coach Can Help)(46:03) The Impact of Alcohol on Gut and Brain Inflammation(50:17) Can Spending Time In Nature Improve Longevity?(53:37) Does Food Timing Really Matter For Overall Health?(01:04:07) WHOOP Advanced Labs(01:04:42) Do GLP-1s Impact The Gut?(01:09:53) Intermittent Fasting: Online Fad or Recommended Path to Wellness(01:16:43) Where To Start: Dr. Shah's Best Advice For Regulating Your Gut(01:18:05) Thanks For Listening!  Follow Dr. ShahInstagramTikTokWebsiteSupport the showFollow WHOOP:Sign up for WHOOP Advanced LabsTrial WHOOP for Freewww.whoop.comInstagramTikTokYouTubeXFacebookLinkedInFollow Will Ahmed:InstagramXLinkedInFollow Kristen Holmes:InstagramLinkedInFollow Emily Capodilupo:LinkedIn 

Sina Azodi, assistant professor of Middle East politics and director of the Middle East Studies program at George Washington University, returns to the show to talk about Iran's nuclear program. The group discusses the Shah's nuclear agenda, Atoms for Peace, Iran's signing of the Nuclear Non-Proliferation Treaty, how the Iran-Iraq War influenced Iran's nuclear policy, missed opportunities for diplomacy after 9/11, Trump's withdrawal from the JCPOA and why Biden didn't revive the deal, and the recent war with Iran.Grab a copy of Sina's book Iran and the Bomb: The United States, Iran, and the Nuclear Question.And contribute to ⁠GiveDirectly's campaign to help survivors of the earthquake in Venezuela⁠.Note: In lieu of a news episode this week, we will be posting an interview relevant to the holiday.Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy